Skip to content
Buy This GLP
How We Assess

Nature of Reviews

Effective September 15, 2026

Our editorial policy explains how we evaluate evidence and verify sources. This page explains how provider scores and paid placements work.

1. What we score

The published scoring rubric shows the weight of each factor. Our clinical research evaluates evidence separately from these provider scores.

  • Price transparency (20%)
  • Honest headline (35%)
  • Dose-ladder pricing (35%)
  • State coverage (5%)
  • Molecule and form breadth (5%)

2. How scores and placement work

Each provider score uses the same published criteria. A provider’s commercial relationship with us does not enter the calculation. See our affiliate disclosures for how commissions work and where they may affect display order.

3. How partners appear

We currently have affiliate links for 30 providers through Katalys. We may earn a commission when an eligible purchase starts from one of those links. Category pages can list partners first. The provider’s score still follows the same rubric.

We label commercial links and show an affiliate disclosure when a page includes one. Our provider reviews explain the pricing, access and evidence behind the verdict so readers can compare providers on those terms.

4. Providers outside our affiliate program

We also review providers with no affiliate relationship and link to their public websites. We use the same scoring criteria for those providers.

5. Coverage and price changes

We do not review every GLP-1 seller in existence. Coverage follows what people are actually deciding between and where evidence exists to decide on. In a compounded market, prices, state availability and regulatory standing move without notice, and recorded prices may be older than a provider’s current quote. Check the current figure before you buy, and treat all of this as research rather than medical advice. If something here is out of date, tell us — we publish the correction.